Nadine McGrath

The ASX 200 burst upwards in morning trade, despite hotter than expected US inflation figures overnight. Chemist Warehouse turns heads.

The ASX 200 flattened out to close a Thursday that saw Chemist Warehouse land on the bourse via Sigma. Mining stocks led the gainers.

Several ASX companies are focused on sports tech, from those working to prevent and treat concussion to others improving athletic performance.

Opyl has entered a joint venture with X Firm to market its TrialKey platform in key markets, while Dimerix has inked another licensing deal. 

Scott Power had his eyes on Sigma Healthcare this week, which soared after the ACCC approves its merger with Chemist Warehouse. 

Online investment platform Stockspot has compiled a list of 13 ETFs which have generated returns above 25% in the past year.

Technology is disrupting traditional medical practices, with locally listed companies at forefront of innovation including Optiscan (ASX:OIL).

Southeast Asia offers strong opportunities for ASX health stocks with an aging population and expanding middle class.

Several ASX companies are conducting clinical trials, and this has become a valuable sector and an asset to the Australian economy.

Australia has a reputation as an attractive clinical trials destination generating $1.6bn for the economy in 2022, according to MTPConnect.